are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial. OBJECTIVE: To compare the effectiveness, complications, and costs of UFH and LMWH as VTE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback